Department of Immunohematology, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
Department of Molecular Diagnostics, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
Transfusion. 2022 May;62(5):1084-1088. doi: 10.1111/trf.16862. Epub 2022 Mar 23.
Exposure to normal or variably expressed RhD antigens in an antigen-negative individual can elicit an immune response and lead to the formation of clinically significant anti-D alloantibodies. We present the case of anti-D alloimmunization by DEL variant missed in routine blood donor screening.
Blood donors were typed for D antigen using the direct serologic micromethod. Nonreactive samples were confirmed in the indirect antiglobulin method with an IgM/IgG anti-D monoclonal reagent. Genomic DNA was extracted using a commercial QIAamp DNA Blood Mini kit on the QIAcube device (Qiaqen, Germany). RHD genotyping was performed using the PCR-SSP genotyping kits- Ready Gene D weak, Ready Gene D weak screen, Ready Gene CDE, and Ready Gene D AddOn (Inno-Train, Germany). Unidentified alleles were sent for DNA genome sequencing.
After identifying DEL positive blood units in RhD negative blood donor pool, a look-back study was performed to determine if their previous donations caused alloimmunization in recipients. Out of 40 D negative recipients, one developed anti-D alloantibody after 45 days. The patient did not receive other RhD positive blood products. Blood donor typed D negative in direct and indirect agglutination method. RHD screening was positive, but RHD genotyping and DNA sequencing showed no mutation indicating the normal genotype.
Currently used methods in RHD genotyping are insufficient to identify many variant alleles, especially intronic variations. We suggest additional gene investigation including yet unexplored regions of regulation and intron regions to justify our serological finding.
在抗原阴性个体中接触正常或可变表达的 RhD 抗原可引发免疫反应,并导致形成具有临床意义的抗-D 同种异体抗体。我们报告了在常规献血者筛查中漏检 DEL 变体导致抗-D 同种免疫的病例。
使用直接血清学微量法对献血者进行 D 抗原分型。非反应性样本在间接抗球蛋白法中使用 IgM/IgG 抗-D 单克隆试剂进行确认。使用 QIAamp DNA Blood Mini 试剂盒(Qiagen,德国)在 QIAcube 设备上提取基因组 DNA。使用 Ready Gene D weak、Ready Gene D weak screen、Ready Gene CDE 和 Ready Gene D AddOn(Inno-Train,德国)的 PCR-SSP 基因分型试剂盒进行 RHD 基因分型。将未识别的等位基因送 DNA 基因组测序。
在 RhD 阴性献血者库中发现 DEL 阳性血液单位后,进行了回溯研究以确定其先前的献血是否导致受血者发生同种免疫。在 40 名 D 阴性受血者中,1 名受血者在 45 天后出现抗-D 同种异体抗体。该患者未接受其他 RhD 阳性血液制品。献血者在直接和间接凝集法中均为 D 阴性。RHD 筛查为阳性,但 RHD 基因分型和 DNA 测序未显示突变,表明正常基因型。
目前用于 RHD 基因分型的方法不足以识别许多变体等位基因,尤其是内含子变异。我们建议进行额外的基因研究,包括尚未探索的调节区和内含子区,以证实我们的血清学发现。